Skip to content
Anagnostics logo — Pioneering systems and tests for research and clinical in-vi...

Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.

Founded 2005 Venture round Total: $3.79M Biotechnology, Health Care

General Information

Company Name Anagnostics
Founded Year 2005
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Anagnostics. To contact Anagnostics, visit anagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Anagnostics compare?

A PDF of Anagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Anagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Anagnostics

Anagnostics is a pioneering company specializing in developing systems and tests for research and clinical in-vitro diagnostics. Established in 2005, the company focuses on addressing unmet needs, particularly in protein and infectious disease diagnostics. Anagnostics aims to provide innovative solutions in the biotechnology and healthcare industries through its cutting-edge technologies. The company received a significant €3.79M Venture Round investment from Tecnet Equity and PP Capital on 27th February 2009, showcasing investor confidence in the company's potential for growth and impact in the diagnostics field.

Business keywords: In-vitro diagnostics, Protein diagnostics, Infectious disease diagnostics, Research, Clinical, Medical research, Laboratory testing, Diagnostic solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €3.79M 2
Tecnet Equity, PP Capital
27 Feb 2009
Venture Round Undisclosed 1
tech2b Inkubator
01 Jan 2003

Anagnostics Alternatives & Competitors

View All Alternatives
Anagnostics vs

Transforming respiratory, infectious, and autoimmune disease with Point of Care diagnostics.

Grant
1 employees
Big Data, Biotechnology
Anagnostics vs

The future of infectious disease diagnostics starts at Day Zero.

64 employees
Biotechnology, Health Care
Anagnostics vs

Precision diagnostics for infectious disease.

Series D
95 employees
Biotechnology, Health Care

FAQ About Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.
Anagnostics was founded in 2005.
Anagnostics operates in Biotechnology and Health Care. Its work centres on In-vitro diagnostics, Protein diagnostics, Infectious disease diagnostics and Research.
Anagnostics has completed 2 funding rounds, raising a total of $3.79M. The latest funding stage is Venture round.
Top alternatives and competitors to Anagnostics include Maven Biotechnologies, Day Zero Diagnostics, Inc, Selux Diagnostics, Inc, Dhiti Omics, Mobidiag, A Hologic Company. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anagnostics and Maven Biotechnologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Anagnostics, https://bouncewatch.com/company/anagnostics, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout